RE: Another Val ...14 Nov 2019 11:27
I agree , especially given two factors
1. Sareum and the aim bio sector has a tendancy for share prices to spike upwards significantly on favourable news
2. we can see that only a couple of trades moves the price up or down . Wait till there is news ie a milestone is confirmed or a licence deal this share price will spike significantly, it has done before and i am sure it will again
I am sure Tim and John are working with a clear focuson the end game
My only concern is whether the incentives are correctly balanced. The longer it takes the more significant salaries are paid toTim and John and BOD, and hopefully a better deal licence /t/o ., especially as a lot of their options are underwater at present.
Risk a competitor beats Sareum to the end game or fail in clinical trial .I would like real incentives to be implemented to in essence to speed matters along and reduce the risk by agreeing a license, t/o or even a JV . Interested to see other investors views are
Good luck all LT H
D.